what glp 1 drugs are fda approved for weight loss Current Strategies in Managing Obesity Wegovy Pill Wins FDA Approval
Description
Recent trials show that overweight or obese patients saw a 14.9% reduction in body weight after taking once-weekly semaglutide 2.4 mg for 68 weeks, compared to a 2.4% reduction in body weight for the control [24]

Similarly, in vitro experiments, approximately 45 bacterial phylotypes were identified to enhance GLP-1 secretion through exposure of NCI H716 L-cells to their cell-free culture supernatants (Tomaro-Duchesneau et al., 2020), co-incubation of Caco-2 cells with Enterococcus faecalis or Mitsuokella multacida supernatants led to a significant reduction in GLP-1 mRNA expression ( E

doi: 10.1016/S0140-6736(10)60307-8 34 NauckMFridAHermansenKShahNSTankovaTMithaIHet al

I would be cautious with that approach
